An OGTT should be carefully considered

in all patients with long-standing HIV infection, low CD4 cell counts and insulin resistance. The authors are grateful to the patients who underwent OGTTs, and to Kevin Smart for revising the text linguistically. No author has potential conflicts of interest to declare. Funding statement This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. “
“Incidence rates (IRs) of Staphylococcus aureus bacteraemia (SAB) are known to be higher in HIV-infected individuals than in the general population, but have not been assessed find more in the era of highly active antiretroviral therapy. From 1 January 1995 to 31 December 2007, all Danish HIV-infected individuals (n=4871) and population controls (n=92 116) matched on age and sex were enrolled in a cohort and all cases of SAB were registered. IRs and risk factors were estimated using time-updated Poisson regression analysis. We identified 329 cases of SAB in 284 individuals, of whom 132 individuals were infected with HIV and 152 were not [crude IR ratio (IRR) 24.2; 95% confidence interval (CI) 19.5–30.0, for HIV-infected

vs. non-HIV-infected individuals]. Over time, IR declined for HIV-infected individuals (IRR 0.40). Injecting drug users (IDUs) had HKI-272 mouse the highest incidence and the smallest decline in IR, while men who have sex with men (MSM) had the largest decline over time. Among HIV-infected individuals, a latest CD4 count <100 cells/μL was the strongest independent predictor of SAB (IRR 10.2). Additionally, HIV transmission

group was associated with risk of SAB. MSM were more likely to have hospital-acquired SAB, a low CD4 cell count and AIDS at the time of HIV acquisition compared with IDUs. We found that the incidence of SAB among Methisazone HIV-infected individuals declined during the study period, but remained higher than that among HIV-uninfected individuals. There was an unevenly distributed burden of SAB among HIV transmission groups (IDU>MSM). Low CD4 cell count and IDU were strong predictors of SAB among HIV-infected individuals. World-wide, hospital-acquired (HA) and community-acquired (CA) Staphylococcus aureus bacteraemias (SABs) are important causes of morbidity and mortality [1]. Individuals infected with HIV are at increased risk of opportunistic and common bacterial infections, and S. aureus ranks as one of the most common causes of bacterial infection [2–5]. Risk factors for invasive S. aureus infection include nasal colonization [6–8], advanced HIV disease [2,3,9], prior hospitalization, neutropenia, skin lesions, injecting drug use (IDU) and the presence of intravascular devices [3,4,10–12]. Further, HIV infection is associated with a higher risk of repetitive SAB [13].